ACP Hospitalist is currently seeking nominations for our 11th annual Top Hospitalists issue. The nomination deadline is July 30, 2018.
The study was terminated early due to low patient recruitment, but it provides evidence that alteplase does not provide significant benefit in mild, nondisabling strokes, according to an accompanying editorial.
The difference in outcomes between black and white patients was only partly eliminated by adjustment for patient and hospital treatment factors, leading study authors to speculate that postacute care contributed to the disparity.
Score may predict Pneumocystis pneumonia in ICU patients with hematologic malignancies and acute respiratory failure
Factors in the score included age, lymphoproliferative disease, prophylactic treatment, time from onset of respiratory symptoms to ICU admission, shock, chest radiograph pattern, and pleural effusion.
For PE in critically ill, half-dose alteplase associated with more treatment escalation than full dose
Mortality and bleeding rates were similar whether critically ill patients with pulmonary embolism (PE) received 50 mg or 100 mg of alteplase, the retrospective study found.